Data collection and analysis
Two authors screened the results of the searches against inclusion criteria, extracted data and assessed risk of bias independently and in duplicate. We calculated mean differences (MD) (standardised mean difference (SMD) when different scales were reported) and 95% confidence intervals (CI) for continuous data. A fixed-effect model was used in the meta-analysis as there were fewer than four studies. We contacted study authors to obtain missing information.
Main results
We included two trials in this review, with 62 participants included in the analyses. Both trials were conducted in university dental schools in the USA and compared the effects of oral penicillin V potassium (penicillin VK) versus a matched placebo when provided in conjunction with a surgical intervention (total or partial pulpectomy) and analgesics to adults with acute apical abscess or symptomatic necrotic tooth. The patients included in these trials had no signs of spreading infection or systemic involvement (fever, malaise). We assessed one study as having a high risk of bias and the other study as having unclear risk of bias.
The primary outcome variables reported in both studies were participant-reported pain and swelling (one trial also reported participantreported percussion pain). One study reported the type and number of analgesics taken by participants. One study recorded the incidence of postoperative endodontic flare-ups (people who returned with symptoms that necessitated further treatment). Adverse effects, as reported in one study, were diarrhoea (one participant, placebo group) and fatigue and reduced energy postoperatively (one participant, antibiotic group). Neither study reported quality of life measurements.
Objective 1: systemic antibiotics versus placebo with surgical intervention and analgesics for symptomatic apical periodontitis or acute apical abscess
Two studies provided data for the comparison between systemic antibiotics (penicillin VK) and a matched placebo for adults with acute apical abscess or a symptomatic necrotic tooth when provided in conjunction with a surgical intervention. Participants in one study all underwent a total pulpectomy of the affected tooth, while participants in the other study had their tooth treated by either partial or total pulpectomy. Participants in both trials received oral analgesics. There were no statistically significant differences in participantreported measures of pain or swelling at any of the time points assessed within the review. The MD for pain (short ordinal numerical scale 0 to 3) was -0.03 (95% CI -0.53 to 0.47) at 24 hours; 0.32 (95% CI -0.22 to 0.86) at 48 hours; and 0.08 (95% CI -0.38 to 0.54) at 72 hours. The SMD for swelling was 0.27 (95% CI -0.23 to 0.78) at 24 hours; 0.04 (95% CI -0.47 to 0.55) at 48 hours; and 0.02 (95% CI -0.49 to 0.52) at 72 hours. The body of evidence was assessed as at very low quality.
Objective 2: systemic antibiotics without surgical intervention for adults with symptomatic apical periodontitis or acute apical abscess
We found no studies that compared the effects of systemic antibiotics with a matched placebo delivered without a surgical intervention for symptomatic apical periodontitis or acute apical abscess in adults.
Authors' conclusions
There is very low-quality evidence that is insufficient to determine the effects of systemic antibiotics on adults with symptomatic apical periodontitis or acute apical abscess.
P L A I N L A N G U A G E S U M M A R Y

The effects of antibiotics on toothache caused by inflammation or infection at the root of the tooth in adults
This Cochrane Review has been produced to assess the effects of antibiotics on the pain and swelling experienced by adults in two conditions commonly responsible for causing dental pain. The review set out to assess the effects of taking antibiotics when provided with, or without, dental treatment.
Background
Dental pain is a common problem and can arise when the nerve within a tooth dies due to progressing decay or injury. Without treatment, bacteria can infect the dead tooth and cause a dental abscess, which can lead to swelling and spreading infection, which can occasionally be life threatening.
The recommended treatment for these forms of toothache is removal of the dead nerve and associated bacteria. This is usually done by extraction of the tooth or root canal treatment (a procedure where the nerve and pulp are removed and the inside of the tooth cleaned and sealed). Antibiotics are only recommended when there is severe infection that has spread from the tooth into the surrounding tissues. However, some dentists still routinely prescribe oral antibiotics to patients with acute dental conditions who have no signs of spreading infection, or without dental treatment to remove the infected material.
Use of antibiotics contributes to the development of antibiotic-resistant bacteria. It is therefore important that antibiotics are only used when they are likely to result in benefit for the patient. Dentists prescribe approximately 8% to 10% of all primary care antibiotics in high-income countries, and therefore it is important to ensure that dentists have good information about when antibiotics are likely to be beneficial for patients.
Study characteristics
The evidence on which this review is based was up-to-date as of 26 February 2018. We searched scientific databases and found two trials, with 62 participants included in the analysis. Both trials were conducted at dental schools in the USA and evaluated the use of oral antibiotics in the reduction of pain and swelling reported by adults after having the first stage of root canal treatment under local anaesthetic. The antibiotic used in both trials was penicillin VK and all participants also received painkillers.
Key results
The two studies included in the review reported that there were no clear differences in the pain or swelling reported by participants who received oral antibiotics compared with a placebo (a dummy treatment) when provided alongside the first stage of root canal treatment and painkillers. However, the studies were small and produced poor quality evidence, and therefore we cannot be certain if the results are correct. Neither study examined the effect of antibiotics on their own, without surgical dental treatment.
One trial reported side effects among participants: one person who received the placebo medication had diarrhoea and one person who received antibiotics experienced tiredness and reduced energy after their treatment.
Quality of evidence
We judged the quality of evidence to be very low. There is currently insufficient evidence to be able to determine the effects of antibiotics in these conditions.
S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Systemic antibiotics with a surgical intervention and analgesics for managing symptomatic apical periodontitis and acute apical abscess in adults Patient or population: adults with a sym ptom atic necrotic tooth or localised acute apical abscess (no signs of spreading inf ection or system ic involvem ent) Settings: university dental schools, USA Intervention: system ic antibiotics, partial or total pulpectom y and analgesics Comparison: m atched placebo, partial or total pulpectom y and analgesics
Outcomes
Illustrative 1, 2, 3 This converts back into a 2% increase (95% CI 55%decrease to 59%in-crease) of control m ean f or antibiotics (based on 1 study at unclear risk of bias)
Adverse effects
During the 3-day f ollow-up period in Fouad 1996, 1 participant in the placebo group reported diarrhoea and 1 participant in the antibiotic group reported f atigue and reduced energy postoperatively * The basis f or the assumed risk (e.g. the m edian control group risk across studies) is provided in f ootnotes. The corresponding risk (and its 95% conf idence interval) is based on the assum ed risk in the com parison group and the relative effect of the intervention (and its 95% CI). CI: conf idence interval.
GRADE Working Group grades of evidence
High quality: f urther research is very unlikely to change our conf idence in the estim ate of ef f ect. M oderate quality: f urther research is likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and m ay change the estim ate. Low quality: f urther research is very likely to have an im portant im pact on our conf idence in the estim ate of ef f ect and is likely to change the estim ate. Very low quality: we are very uncertain about the estim ate.
B A C K G R O U N D Description of the condition
Dental pain can have a detrimental effect on an individual's social functioning and quality of life (Pau 2005; Reisine 1995) . In the UK Adult Dental Health Survey of 2009, 29% of individuals reported experiencing dental pain "occasionally" or "fairly/very often" during the preceding 12 months. The overall prevalence of dental pain among survey respondents was 9%, with higher values reported for younger individuals and those from lower socioeconomic groups (Steele 2011). Among adults presenting with acute dental conditions, approximately 16% will have symptomatic apical periodontitis and a further 20% will have an acute apical abscess (Cope 2016). Apical periodontitis arises following injury to the pulpal tissues of a tooth caused by dental caries, tooth fracture, trauma, or iatrogenic damage. While the dental pulp can recover from reversible pulpitis resulting from a mild to moderate injury, persistent or extensive damage results in irreversible levels of inflammation within the pulpal tissues. Should this occur, an individual might experience symptoms of irreversible pulpitis. Without treatment, irreversibly inflamed teeth then undergo pulpal necrosis and bacterial colonisation of the root canal system (Abbott 2004; Bergenholtz 2010). Apical periodontitis (also known as periapical periodontitis) is an inflammatory lesion of the periradicular tissues that arises principally due to the egress of irritants, such as bacteria and toxins, from an inflamed or necrotic pulp (Torabinejad 1994) . Its evolutionary role is protective: to contain the root canal bacteria and prevent the spread of infection. While the vast majority of cases are asymptomatic, exacerbations of apical periodontitis can present as symptomatic apical periodontitis or an acute apical abscess(Bergenholtz 2010). Symptomatic apical periodontitis can arise either from a formerly healthy tooth that has subsequently undergone pulpal breakdown or from a tooth with a previously asymptomatic apical periodontitis. It is characterised by a dull or throbbing pain that is exacerbated by biting. The affected tooth usually has a negative or delayed positive response to vitality testing and is often highly sensitive to percussive forces (Bergenholtz 2010). It should be noted that in determining the health of pulpal tissues, the term 'vitality testing' is commonly used. True 'vitality' tests attempt to examine the presence of pulp blood flow, while 'sensibility' tests employ the use of thermal or electrical stimuli to elicit a response from innervated tissue (Chen 2009). Although neither can definitively indicate the health of the dental pulp, they remain useful diagnostic aids, commonly used in both clinical practice and scientific studies. Acute apical abscesses develop in the presence of a pre-existing apical periodontitis (Carrotte 2004) . The persistent presence of infective material within the pulpless root canal system and around the apex of a tooth can lead to a massive influx of polymorphonuclear leukocytes into the periradicular tissues, leading to tissue liquefaction and pus formation (Bergenholtz 2010) . Also known as a periapical, dentoalveolar, or alveolar abscess, an apical abscess is characterised by the accumulation of pus in the periradicular tissues and can present as either an acute or a chronic lesion. Individuals with acute apical abscesses typically complain of a rapid onset, spontaneous pain, tenderness of the tooth to pressure, pus formation, and swelling of associated tissues (Glickman 2009). Left untreated, the abscess may spread, resulting in a potentially serious head and neck infection accompanied by fever, malaise, and lymph node involvement (Abbott 2004). Since symptomatic apical periodontitis and acute apical abscess represent a continuum of the same disease process, it is appropriate to consider both conditions in this review (Sutherland 2004) .
Description of the intervention
Clinical guidelines currently recommend that the first-line treatment for teeth with either symptomatic apical periodontitis or an acute apical abscess is the removal of the source of inflammation or infection by local, operative measures (Glenny 2004; SDCEP 2016) . This could involve extraction of the offending tooth or extirpation (removal) of the pulpal tissues, possibly in combination with the incision and drainage of any swelling present. Systemic antibiotics are currently only recommended for situations where there is evidence of spreading infection (cellulitis, lymph node involvement, diffuse swelling) or systemic symptoms (fever, malaise) (Palmer 2015; SDCEP 2016) . Despite this, there is evidence that antibiotics are often prescribed by dentists to patients with symptomatic apical periodontitis or acute apical abscess in the absence of these signs (Cope 2016; Germack 2017; Segura-Egea 2010; Yingling 2002) . In a study, 69% of individuals attending a British out-of-hours dental clinic with symptomatic apical periodontitis received a prescription for systemic antibiotics, many in the absence of a surgical intervention (Dailey 2001) .
How the intervention might work
Doctors and dentists may prescribe systemic antibiotics to minimise the signs and symptoms of symptomatic apical periodontitis or acute apical abscess, and to treat or prevent the development of a serious orofacial swelling with systemic involvement. Antibiotics can be prescribed as an adjunctive or stand-alone treatment. People prescribed antibiotics may be given analgesics at the same time.
Why it is important to do this review
There is international concern about the overuse of antibiotics and the emergence of antibiotic-resistant bacterial strains (World 
O B J E C T I V E S
To evaluate the effects of systemic antibiotics provided with or without surgical intervention (such as extraction, incision and drainage of a swelling, or endodontic treatment), with or without analgesics, for symptomatic apical periodontitis or acute apical abscess in adults.
M E T H O D S
Criteria for considering studies for this review
Types of studies
We included randomised controlled trials (RCTs) with parallel group design in the review. We excluded cluster RCTs.
Types of participants
Studies of adults (18 years of age or older), male or female, who presented with a single tooth with a clinical diagnosis of either symptomatic apical periodontitis or acute apical abscess.
Types of interventions Active intervention
Administration of any systemic antibiotic (either oral or intravenous) at any dosage prescribed in the symptomatic phase of apical periodontitis or acute apical abscess with or without analgesics, and with or without surgical intervention (extraction, incision and drainage or endodontic treatment).
Control
Administration of a matched placebo prescribed in the symptomatic phase of apical periodontitis or acute apical abscess with or without analgesics, and with or without surgical intervention. 
Types of outcome measures
Search methods for identification of studies Electronic searches
Cochrane Oral Health's Information Specialist conducted systematic searches in the following databases for randomised controlled trials and controlled clinical trials. There were no language, publication year or publication status restrictions:
• Subject strategies were modelled on the search strategy designed for MEDLINE Ovid. Where appropriate, they were combined with subject strategy adaptations of the highly sensitive search strategy designed by Cochrane for identifying randomised controlled trials and controlled clinical trials as described in the Cochrane Handbook for Systematic Reviews of Interventions, Chapter 6 (Lefebvre 2011). The full search strategies used for each database can be found in Appendix 1.
Searching other resources
The following trial registries were searched for ongoing studies:
• US National Institutes of Health Ongoing Trials Register ClinicalTrials.gov (clinicaltrials.gov; searched 26 February 2018);
• World Health Organization International Clinical Trials Registry Platform ( apps.who.int/trialsearch; searched 26 February 2018).
We checked the reference lists of all included and excluded studies to identify any further trials. We did not perform a separate search for adverse effects of interventions used, we considered adverse effects described in included studies only.
Data collection and analysis
Selection of studies
Two review authors (Anwen L Cope (ALC) and Ivor G Chestnutt (IGC)) independently assessed the titles and abstracts (where available) of the articles identified by the search strategy and made decisions regarding eligibility. The search was designed to be sensitive and include controlled clinical trials, these were filtered out early in the selection process if they were not randomised. Fulltext versions were obtained for all articles being considered for inclusion, as were those with insufficient information in the title or abstract to make a clear decision. We resolved any disagreements by discussion. We excluded studies later found not to meet the inclusion criteria and recorded them in the Characteristics of excluded studies table.
Data extraction and management
We entered study details into the Characteristics of included studies table. ALC and IGC independently extracted the outcome data from the included studies using a standard data extraction form. The review authors discussed the results and resolved any disagreements. In cases where uncertainties persisted, we contacted the study authors for clarification. We extracted the following characteristics of the studies.
1. Study methodology: study design, methods of allocation, method of randomisation, randomisation concealment, blinding, time of follow-up, loss to follow-up, country conducted in, number of centres, recruitment period and funding source.
2. Participants: sampling frame, diagnostic criteria, inclusion criteria, exclusion criteria, number of participants in each group, baseline group demographics and clinical diagnosis.
3. Intervention: type of antibiotic, dose, frequency and duration of course. Information about co-interventions, for example, surgical treatment or analgesia.
4. Outcomes: primary outcomes at 24, 48 and 72 hours and 7 days, and secondary outcomes as previously described (see Primary outcomes; Secondary outcomes).
Assessment of risk of bias in included studies
Two review authors (ALC and IGC) independently assessed the risk of bias of the included studies and resolved any disagreements by discussion. We completed a 'Risk of bias' table for each included study following the recommended methods for assessing the risk of bias in studies included in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). This was a two-part tool addressing specific key domains including sequence generation, allocation concealment, blinding, incomplete outcome data, selective outcome reporting and other bias. We tabulated relevant information describing what happened, as reported in the study or revealed by correspondence with the study authors, for each included study, along with a judgement of low, high or unclear risk of bias for each individual domain. A summary assessment of the risk of bias of each included study was made as follows:
• low risk of bias (plausible bias unlikely to seriously alter the results) if we assessed all key domains to be at low risk of bias;
• unclear risk of bias (plausible bias that raises some doubt about the results) if we assessed one or more key domains as unclear;
• high risk of bias (plausible bias that seriously weakens confidence in the results) if we assessed one or more key domains to be at high risk of bias.
We completed a 'Risk of bias' table for each included study. We also presented the results graphically.
Measures of treatment effect
For dichotomous outcomes, we expressed the estimate of effect of the intervention as risk ratios (RR) together with 95% confidence intervals (CI). For continuous outcomes (such as mean VAS scores), we reported mean differences (MD) (or standardised mean differences (SMD) when different scales measuring the same concept) and their corresponding 95% CI.
Unit of analysis issues
We anticipate that, by the nature of the outcome variables being recorded, studies included in future updates may involve repeat observations. Results from more than one time point for each study cannot be combined in a standard meta-analysis without a unit-of-analysis error. Therefore, we assessed outcomes at 24, 48 and 72 hours and 7 days postoperatively, as the data allowed. We included no clustered trials in the review. Given the nature of the conditions and intervention under review, it is high unlikely any cross-over trials will be suitable for inclusion in the future. In updates, we will consider multi-arm studies for inclusion in the review, in accordance with recommendations in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011), we will combine all relevant experimental groups and considered them as a single group and compared them with a combined group of all the control groups, if present.
Dealing with missing data
We contacted the original investigators in cases of missing data.
Assessment of heterogeneity
We planned to assess heterogeneity using the Chi 2 test (P value < 0.10 regarded as statistically significant). For studies judged as clinically homogeneous, we test heterogeneity using the I 2 statistic, as recommended in the Cochrane Handbook for Systematic Reviews of Interventions (Higgins 2011). The I 2 statistic describes the percentage of variability in effect estimates that is due to heterogeneity rather than sampling error. An I 2 of 0% to 40% might not be important, 30% to 60% may represent moderate heterogeneity, 50% to 90% may have substantial heterogeneity, and 75% to 100% studies has substantial heterogeneity.
Assessment of reporting biases
We examined within-study selective outcome reporting as a part of the overall risk of bias assessment and contacted study authors for clarification. If there had been at least 10 studies included in a meta-analysis, we would have assessed between-study reporting bias by creating a funnel plot of effect estimates against their standard errors. If we had found asymmetry of the funnel plot by inspection and confirmed this by statistical tests, we would have considered possible explanations and taken into account in the interpretation of the overall estimate of treatment effects.
Data synthesis
We only carried out meta-analysis where studies of similar comparisons, reported similar outcomes, for people with similar clinical conditions. We combined MDs (or SMDs where studies had used different scales) for continuous outcomes, and combined RRs for dichotomous outcomes, using a fixed-effect model if there were only two or three studies, or a random-effects model if there were four or more studies.
Subgroup analysis and investigation of heterogeneity
We planned to investigate clinical heterogeneity by examining the following subgroups should sufficient data have been available.
1. Different antibiotic class (e.g. penicillins versus macrolides).
2. The effects of accompanying surgical intervention (extraction, incision and drainage or endodontic treatment).
Sensitivity analysis
Provided there were sufficient studies for each outcome and intervention, we had planned to undertake sensitivity analysis based on trials judged to be of low risk of bias.
Presentation of main results
We developed a 'Summary of findings' table for the primary outcomes of this review using GRADEPro software (GRADEpro GDT 2015) , with the GRADE assessment of the quality of the body of evidence.
R E S U L T S Description of studies Results of the search
After de-duplication, the electronic searches conducted in 2013 yielded 625 references. We identified one additional trial by checking the bibliographies of the selected trials and reviews (Al-Belasy 2003) . After examination of the titles, and abstracts where available, we excluded 590 references from further analysis. We obtained full-text copies of the remaining 36 trials, translated them where required, and subjected them to further evaluation. At this stage, we excluded 34 studies and recorded their characteristics (Characteristics of excluded studies). After de-duplication, the electronic searches conducted for the current update (February 2018) yielded an additional 190 references not included in the previously published version. We retrieved no additional citations from other sources. After examination of the titles and abstracts where available, we excluded all 190 references from further analysis (Figure 1 ). 
Included studies
Two randomised controlled trials (RCTs) satisfied the inclusion criteria (Fouad 1996; Henry 2001) . See Characteristics of included studies table for further details.
Characteristics of trial designs and settings
Both studies were of parallel group design, one had three arms (Fouad 1996) , and the other had two arms (Henry 2001) . Both studies were conducted at university dental schools in the USA and based at a single centre. One study was supported by a university research fund and the other did not declare funding sources. Neither study reported sample size calculations.
Characteristics of participants
We included 62 participants in the analysis for this review, with 21 people analysed in Fouad 1996, and 41 people analysed in Henry 2001. Both studies were conducted on otherwise healthy adults. Participants in one study had a mean age of 36 years (standard deviation (SD) 13.7 years) and had a clinical diagnosis of acute apical abscess with pulpal necrosis, periapical pain or swelling, or both (Additional Table 1 ; Fouad 1996) . Potential participants were excluded if their temperature was elevated (judged by investigators to be above 100°F (37.8°C) or if they had was malaise or fascial space involvement. Participants in the other study had a mean age of 37 years (SD 16.5 years) in the penicillin arm and 38 years (SD 18.8 years) in the placebo arm (Additional Table 2 ; Henry 2001). All had a symptomatic necrotic tooth with a periapical radiolucency and no mucosal sinus tract (Henry 2001). One trial had more male participants (Fouad 1996) and the other had similar numbers of male and female participants (Henry 2001) . There were no significant differences in the intra-study baseline characteristics of participants (Additional Table 1 ; Additional Table 2 ).
Characteristics of intervention
Objective 1: systemic antibiotics versus a matched placebo provided in conjunction with a surgical intervention
In one trial, participants underwent total or partial pulpectomy under local anaesthesia with temporary restoration at the baseline visit (Fouad 1996) . In the other trial, all participants underwent total pulpectomy with temporary restoration at the baseline visit (Henry 2001).
In the study by Fouad 1996, participants in the penicillin group received oral penicillin (phenoxymethyl) VK 1 g following treatment and then 500 mg, every 6 hours for 7 days. Participants in the placebo group received an oral matched placebo taken according to the same regimen. In the trial by Henry 2001, participants in the penicillin group received 500 mg oral penicillin VK tablets (Wyeth Laboratories, Philadelphia, PA) which they were instructed to take every 6 hours for 7 days. Participants in the placebo group received an oral matched placebo (lactose) taken according to the same regimen. In one trial, all participants also received ibuprofen 600 mg immediately before treatment, on four occasions during the next 24 hours, and then as required (Fouad 1996) . In the other trial, all participants received a bottle of ibuprofen 200 mg tablets (Advil, Whitehall Laboratories, New York, NY) with instructions to take two tablets every 4 to 6 hours as required. Each participant also received a labelled bottle of paracetamol (acetaminophen) with codeine (Tylenol #3, McNeil Consumer Products, Fort Washington, PA) with dosing instructions, to take if two ibuprofen did not relieve their discomfort. One participant was given Percocet (oxycodone plus paracetamol (acetaminophen)) instead (Henry 2001).
Objective 2: systemic antibiotics versus a matched placebo provided without a surgical intervention
We found no studies comparing systemic antibiotics versus a matched placebo provided without a surgical intervention.
Heterogeneity of interventions
There was heterogeneity with respect to the operative treatment, doses of antibiotics given to participants in the intervention arms and type, dose and frequency of analgesics provided to participants between the two studies.
Characteristics of the outcome measures
Primary outcomes
Both studies reported participant-reported pain. Both utilised a short ordinal numerical scale graded from 0 to 3. In Fouad 1996, this score was determined by converting the value from a VAS on the post-treatment card into a whole number rank. Pain was measured at the following data points:
• 6 hours, 12 hours, 24 hours, 48 hours and 72 hours (Fouad 1996);
• day 1, day 2, day 3, day 4, day 5, day 6, day 7 (Henry 2001).
Both studies also reported participant-reported swelling. In Henry 2001, investigators utilised a short ordinal numerical scale graded from 0 to 3. In Fouad 1996, increase or decrease in swelling compared with baseline was recorded on a short ordinal numerical scale graded from 0 to 4. Swelling was measured at the following data points:
One study included percussion pain (Henry 2001). This was measured on a short ordinal numerical scale graded from 0 to 3. One study included incidence of endodontic flare-up (Fouad 1996) . This was measured dichotomously and was clinician-assessed based on the presence of: no relief or an increase in the severity of pain; no resolution or an increase in the size of swelling, fever, trismus or difficulty swallowing; signs of a drug allergy or any other abnormal symptoms.
Secondary outcomes
One study included the number and type of analgesics required (Henry 2001). In Fouad 1996, participants recorded whether they required additional analgesia; however, this information was not reported and was not available after contacting the investigators. One study reported adverse effects (Fouad 1996) .
Handling of data/data assumptions made in the review
For objective 1, we compared pain and swelling scores at 24, 48 and 72 hours and 7 days postoperatively. For the purposes of the analysis, we made the assumption that the data points from Henry 2001 (day 1, day 2 and day 3) were sufficiently analogous to those measure in Fouad 1996 to be combined.
Excluded studies
We excluded the majority of references as they were not RCTs.
Other excluded studies did not report relevant health outcomes, had no placebo control or had other characteristics that did not satisfy the inclusion criteria (see Characteristics of excluded studies table).
Risk of bias in included studies
The review authors' judgements about each risk of bias item for each included study are given in Figure 2 . 
Allocation Randomisation
We considered both studies to be at low risk of bias for random sequence generation.
Allocation concealment
We assessed both studies to have adequate concealment of allocation prior to assignment. In Fouad 1996, individuals enrolling participants into the trial were not aware of the upcoming allocation sequence; envelopes were sequentially numbered, opaque and sealed; envelopes for the penicillin and placebo groups were identical in appearance and weight and were only opened after being assigned to the participant. In Henry 2001, participants were given sequentially numbered drug containers of identical appearance in accordance with the randomisation sequence produced prior to the experiment.
Blinding
We judged both studies to have employed adequate measures to ensure that active and placebo tablets had identical appearance, and, therefore, we considered risk of performance bias to be low for both studies. Similarly, we considered both studies to have low risk of detection bias as blinding was unlikely to have been broken.
Incomplete outcome data
We considered Fouad 1996 to be at high risk of attrition bias.
Rates of withdrawal were in excess of 20% in across groups, with higher rates of withdrawal from the placebo than the penicillin group. We judged differential attrition as likely to be related to treatment outcomes. In Henry 2001, we were unable to judge risk of bias due to insufficient reporting of relative attrition rates and reasons for withdrawal and, therefore, this risk for this domain is 'unclear'.
Selective reporting
We judged one study to be at unclear risk of reporting bias, as investigators did not report whether the need for additional analgesia differed between the two trial arms, although this information was collected on the post-treatment card (Fouad 1996) . There was no evidence of selective reporting within Henry 2001 and all expected outcomes were presented. We judged this study to be at low risk of reporting bias.
Other potential sources of bias
We judged both trials to be at low risk of other potential sources of bias.
Overall risk of bias
One study had high overall risk of bias (Fouad 1996) , and one had unclear risk of bias (Henry 2001) ( Figure 2 ).
Effects of interventions
See: Summary of findings for the main comparison Systemic antibiotics with a surgical intervention and analgesics for managing symptomatic apical periodontitis and acute apical abscess in adults Objective 1: systemic antibiotics versus a matched placebo provided in conjunction with a surgical intervention Two studies, one at unclear risk of bias (Henry 2001) , and one at high risk of bias (Fouad 1996) , provided data for this comparison. Both compared oral penicillin V potassium K (penicillin VK) against a matched placebo when provided alongside partial or total pulpectomy for adults with localised acute apical abscess or symptomatic necrotic tooth in otherwise healthy adults.
Primary outcomes
Pain
The analysis of participant-reported pain at data points 24, 48 and 72 hours was based on data from two studies (61 participants), one at high risk of bias (Fouad 1996) , and one at unclear risk of bias (Henry 2001) . Analysis of the 7-day time point was based on data from one study (41 participants) at unclear risk of bias (Henry 2001). For the antibiotic group:
• mean difference (MD) at 24 hours -0.03 (95% confidence interval (CI) -0.53 to 0.47);
• MD at 48 hours 0.32 (95% CI -0.22 to 0.86);
• MD at 72 hours 0.08 (95% CI -0.38 to 0.54);
• MD at 7 days -0.05 (95% CI -0.41 to 0.30, P value = 0.77).
Swelling
The analysis of participant-reported swelling at data points 24 hours (61 participants), 48 hours (62 participants) and 72 hours (61 participants) was based on data from two studies, one at high risk of bias (Fouad 1996) , and one at unclear risk of bias (Henry 2001). Analysis of 7-day time point was based on data from one study at unclear risk of bias (Henry 2001). Standardised mean difference (SMD) was used to combine the different scales used for the 24-, 48-and 72-hour data points. For the antibiotic group:
• SMD at 24 hours 0.27 (95% CI -0.23 to 0.78). This converts back into a 36% increase (95% CI 31% decrease to 105% increase) of control mean for antibiotics. Re-expressed from the SMD into the short ordinal numerical scale used by Henry 2001. Results should be interpreted with caution since back-translation of the effect size was based on the results of only one study;
• SMD at 48 hours 0.04 (95% CI -0.47 to 0.55). This converts back into a 4% increase (95% CI 49% decrease to 58% increase) of control mean for antibiotics. Re-expressed from the SMD into the short ordinal numerical scale used by Henry 2001. Results should be interpreted with caution since back-translation of the effect size was based on the results of only one study;
• SMD at 72 hours 0.02 (95% CI -0.49 to 0.52). This converts back into a 2% increase (95% CI 55% decrease to 59% increase) of control mean for antibiotics. Re-expressed from the SMD into the short ordinal numerical scale used by Henry 2001. Results should be interpreted with caution since back-translation of the effect size was based on the results of only one study;
• MD at 7 days 0.02 (95% CI -0.28 to 0.32, P value = 0.90).
Percussion pain
The analysis of participant-reported percussion data at data points 24, 48 and 72 hours was based on data from one study (41 participants) at unclear risk of bias (Henry 2001). For the antibiotic group:
• MD at 24 hours -0.32 (95% CI -0.85 to 0.21, P value = 0.24);
• MD at 48 hours 0.09 (95% CI -0.44 to 0.62, P value = 0.74);
• MD at 72 hours 0.05 (95% CI -0.55 to 0.65, P value = 0.87);
• MD at 7 days 0.06 (95% CI -0.29 to 0.41, P value = 0.73).
Endodontic flare-up
The analysis of clinician-assessed incidence of endodontic flareup over 3-day follow-up period was based on data from one study at high risk of bias (20 participants) (Fouad 1996) . For the antibiotic group:
• risk ratio (RR) of endodontic flare-up 0.27 (95% CI 0.01 to 4.90, P value = 0.37).
Secondary outcomes
Analgesics
The analysis of the number of analgesic tablets required during the 7-day follow-up period was based on data from one study (41 participants) at unclear risk of bias (Henry 2001). For the antibiotic group:
• MD for total number of ibuprofen tablets 1.58 (95% CI -4.55 to 7.71, P value = 0.62).
• MD for total number of paracetamol (acetaminophen) with codeine tablets -0.31 (95% CI -3.94 to 3.32, P value = 0.87).
Adverse effects
During the 3-day follow-up period in Fouad 1996 (20 participants, high risk of bias), one participant in the placebo group reported diarrhoea and one participant in the antibiotic group reported fatigue and reduced energy postoperatively.
Objective 2: systemic antibiotics versus a matched placebo provided without a surgical intervention
D I S C U S S I O N Summary of main results
The review process identified two studies suitable for inclusion, both of which assessed the effects of penicillin VK compared with a matched placebo in adults with localised apical abscess or a symptomatic necrotic tooth (no signs of spreading infection or systemic involvement) when provided in conjunction with partial or total pulpectomy conducted under local anaesthesia, and oral analgesics. There were no statistically significant differences in primary outcomes (participant-reported pain, swelling or percussion pain or incidence of endodontic flare-up) or secondary outcomes (analgesic use or incidence of adverse events) between participants who had received antibiotics and participants who had received a matched placebo. We considered this body of evidence (two studies, one at unclear risk of bias and one at high risk of bias) to be of very low quality and therefore the results should be interpreted with caution. We found no studies that reported the effects of systemic antibiotics versus a matched placebo for symptomatic apical periodontitis when provided in conjunction with a surgical intervention. We found no studies that reported the effects of systemic antibiotics versus a matched placebo for symptomatic apical periodontitis or acute apical abscess when provided without a surgical intervention.
Overall completeness and applicability of evidence
We employed a comprehensive search strategy and we are confident that the majority of published trials are included in this review. We made efforts to identify all relevant studies and excluded no studies due to language. The two included trials partially addressed the first of the two objectives (Fouad 1996; Henry 2001), which both investigated the effect of systemic antibiotics for acute apical abscess or symptomatic necrotic tooth provided in conjunction with total or partial pulpectomy in adults. However, there were no trials that assessed the effects of antibiotics for symptomatic apical periodontitis when used in conjunction with a surgical intervention. Furthermore, we found no trials assessing the second objective, which sought to compare antibiotics and a placebo for symptomatic apical periodontitis or acute apical abscess when provided without a surgical intervention. The participants included in the two trials can be considered broadly representative of people who would consult a dentist due to an acute apical abscess or symptomatic necrotic tooth who do not have evidence of spreading infection or systemic involvement: participants came from a wide age range, were about equal gender mix and the majority had moderate pain at the baseline visit. However, both the trials excluded participants with co-morbidities or who may have been immunocompromised. Therefore, the results of this review may not be generalisable to a group of people who may be at higher risk of infection. While future trials should endeavour to obtain a representative sample, it is unlikely to be feasible or ethical to conduct placebo-controlled trials in these groups of people. One trial excluded participants with signs of spreading infection and systemic involvement (Fouad 1996) , and the other trial included only a small number of participants with evidence of severe infections at baseline (Henry 2001). Therefore, the results of this review may not be generalisable to people with severe swelling or other signs of spreading infection or systemic involvement. Both of the included studies were conducted at university dental schools and, in both trials, endodontic treatment was completed by practitioners who either worked in the Department of Endodontics (Fouad 1996) , or were senior endodontic graduate students (Henry 2001). It would be reasonable to consider that both groups of practitioners had endodontic skills in excess of those of an average primary care dentist. The specialist settings in which the trials were conducted were also unlikely to face the time constraints encountered in routine clinical practice. Therefore, the intervention provided within these studies may only have limited applicability to the treatment routinely provided at emergency appointments in general dental practice, where treatment decisions are often dictated by time pressures (Palmer 2000) . Therefore, more trials in a primary care setting would enhance the evidence base for answering the questions posed by this review. We found no trials assessing the effect of other surgical interventions, such as dental extraction, or incision and drainage of a swelling. Since dental extraction is a common treatment for both symptomatic apical periodontitis and acute apical abscess (Cope 2016), the effects of this intervention could be considered in future trials. The outcomes reported by the two trials measured the harms as well as the benefits of interventions. This is important as antibiotics can have adverse effects such as hypersensitivity reactions, gastrointestinal upset, and the risk of development of antibioticresistant bacterial colonies. Many of the outcome measures in the two included trials were participant-centred, such as pain, percussion pain and swelling. Since both pain and discomfort are known to impact an individual's quality of life (Skevington 1998), future trials should also consider formally measuring oral health-related quality of life outcomes to assess the beneficial and harmful effects of this intervention in more detail.
Quality of the evidence
The quality of the evidence, as summarised in Summary of findings for the main comparison for the main comparison, was rated as very low. Given the considerable number of antibiotics prescribed by dentists to adults with acute dental conditions and the problems associated with indiscriminate use of antibiotics, the paucity of highquality trials evaluating the effects of systemic antibiotics in the management of symptomatic apical periodontitis and acute apical abscess is disappointing. Only two studies met the inclusion criteria for this review; we judged one to be at high risk of bias and the other to be of unclear risk of bias. Both had methodological flaws with respect to attrition bias, and the overall quality of evidence was very low. Furthermore, small group sizes mean that both studies were likely to lack the statistical power to detect differences between intervention and placebo groups. Sample size calculations were not reported in either study. Therefore, caution should be exercised when interpreting the results presented in this review.
Potential biases in the review process
Two independent review authors extracted data and assessed the methodological quality of each study, minimising potential bias. We are confident that the extensive literature search used in this review has captured relevant literature and minimised the likelihood that we missed any relevant trials. We applied no language or publication restrictions in our search. In the event of incomplete or unclear reporting of trial data, we contacted the trial authors to obtain any unpublished data or clarification of results. Despite these efforts, it must be acknowledged that there is a small possibility that there were additional studies (published and unpublished) that we did not identify. It is possible that additional literature searches, such as searching non-English language databases and handsearching relevant journals, would have found additional studies.
Agreements and disagreements with other studies or reviews
Systematic reviews of the emergency management of acute apical periodontitis and acute apical abscess in the permanent dentition were published in 2003 (Matthews 2003; Sutherland 2003) . These reviews had wider inclusion criteria and included trials of analgesics, local pharmacotherapeutics and surgical interventions in addition to antibiotic trials. Sutherland 2003 concluded that "the use of antibiotics in the management of AAP [acute apical periodontitis] is not recommended" and Matthews 2003 recommended that "the use of antibiotics in the management of localized AAA [acute apical abscess] over and above establishing drainage of the abscess, is not recommended".
A U T H O R S ' C O N C L U S I O N S Implications for practice
Based on the current available data, which are of very low quality, there was insufficient evidence to determine the effects of the administration of systemic antibiotics to adults with symptomatic apical periodontitis or acute apical abscess.
Since antibiotic use is recognised as a major contributor to antimicrobial resistance, dental professionals should be judicious in their use of these agents and should refer to evidence-based best practice guidelines when managing people with acute dental conditions.
Implications for research
Large-scale, adequately powered and well-designed randomised controlled trials are needed to clarify the effectiveness of systemic antibiotics in the treatment of symptomatic apical periodontitis and acute apical abscess. However, all future trials should be carefully designed to ensure the potential benefits of providing systemic antibiotics to participants outweigh risks associated with antibiotic usage, both adverse effects and the possible contribution to antibiotic resistance.
Future studies should consider both utilising validated participant-and clinician-reported outcome measures, and report results according to CONSORT guidelines ( www.consortstatement.com/).
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Reisine 1995
Reisine S, Locker D. Social, psychological and economic impacts of oral conditions treatments. In: Cohen LK, Gift HC editor(s Included participants had a clinical diagnosis of acute apical abscess with pulpal necrosis with periapical pain or swelling, or both Participants were excluded if they had: elevated temperature (above 37.8 ºC (100 ºF) ; malaise; fascial space involvement; allergy to penicillin or cephalosporins; diseases or medications compromising the immune system; renal failure or any other significant renal or hepatic impairment; people who had taken antibiotics in the 2-week period prior to their visit; pregnant or lactating or taking oral contraceptives Number of participants at randomisation: group 1 = 13; group 2 = 15 Number of participants included in the analysis: group 1 = 10; group 2 = 11 Interventions Endodontic treatment: all participants had the affected tooth treated by total or partial pulpectomy on day 0. This involved delivery of local anaesthesia, assessment of the tooth, determination of working length, partial/total cleaning and shaping of the canals with copious irrigation with 2.6% sodium hypochlorite. Canals were dried and calcium hydroxide paste applied and the access cavity temporised with Cavit T M (a light-cured temporary sealing compound for temporary restoration of cavities) or IRM® (intermediate restorative material is a polymer-reinforced zinc oxide-eugenol composition restorative material designed for intermediate restorations). Some participants also underwent incision and drainage of a localised intraoral swelling, if judged to be clinically indicated Participants were then assigned to a trial arm: Group 1: oral penicillin (phenoxymethyl) VK 500 mg, 1 g after endodontic treatment followed by 500 mg 6-hourly for 7 days Group 2: oral matched placebo taken according to the same regimen Group 3: neither medication group Analgesics: all participants received ibuprofen 600 mg immediately before treatment, 4 times daily for 24 hours and then as needed
Segura-Egea 2010
C H A R A C T E R I S T I C S O F S T U D I E S Characteristics of included studies [ordered by study ID]
Fouad 1996
Methods
RCT
Outcomes
Primary outcomes
Participants were required to complete a post-treatment card recording their experiences up to 3 days postoperatively. This card was then returned to the authors via post. Pain was assessed using a VAS, which was then converted into a short ordinal numerical scale from 0 to 3: 0 indicated pain of no clinical significance; 1 = mild pain; 2 = moderate pain;
Fouad 1996 (Continued) 3 = severe pain. Postoperative swelling relief was recorded on a simple categorical scale ('no swelling', 'much less', 'slightly less', 'same', 'slightly more') with participants required to compare current levels of swelling to those they had experienced preoperatively. The categorical scale was then given scores from 0 to 4: 0 = no swelling; 1 = significant reduction in swelling; 2 = slight decrease in swelling; 3 = same size swelling as before; 4 = an increase in the size of swelling Incidence of flare-up: measured dichotomously and was clinician-assessed based on the presence of: no relief or an increase in the severity of pain; no resolution or an increase in the size of swelling, fever, trismus or difficulty swallowing; signs of a drug allergy or any other abnormal symptoms Interventions Endodontic treatment: all participants underwent total pulpectomy of the affected tooth on day 0. Canals were prepared using a step-back preparation and K-type files (LD Caulk, Inc, Milford, DE) and irrigated with 2.62% hypochlorite. Following instrumentation, canals were dried and a temporary restoration placed (Cavit T M (a light-cured temporary sealing compound for temporary restoration of cavities)) Participants were then assigned to a trial arm Group 1: oral penicillin (phenoxymethyl) VK 500 mg, 6-hourly for 7 days Group 2: oral matched placebo taken according to the same regimen Analgesics: all participants received a supply of ibuprofen and were advised to take 400 mg (2 x 200 mg tablets) every 4-6 hours, as required. Each participant also received a labelled bottle of paracetamol (acetaminophen) with codeine (30 mg), which they were instructed to take 1 or 2 tablets every 4 hours only if 2 ibuprofen tablets did not relieve their discomfort
Outcomes
Primary outcomes
Participant-reported pain, percussion pain and swelling experience at the baseline visit and upon rising for 7 days after treatment on categorical scales. Participants received a 7-day diary to record postoperative symptoms upon rising each day. This was returned at the obturation appointment (typically the end of root canal treatment). Pain was assessed using a short ordinal numerical scale from 0 to 3: 0 = no pain; 1 = mild pain; 2 = moderate pain; 3 = severe pain. Participants used the same scale to rate pain to percussion (achieve by tapping the affected tooth with a finger). Swelling was assessed on a similar ordinal numerical scale from 0 to 3: 0 = no swelling; 1 = mild swelling, a mild puffiness that was not bothersome; 2 = moderate swelling that caused facial distortion and was bothersome; 3 = a severe swelling that caused serious facial distortion and was very bothersome
Secondary outcomes
The number and type of pain medication taken 
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